amphotericin b

amphotericin b is a lipid of Polyketides (PK) class. Amphotericin b often locates in Mitochondria.

Cross Reference

Introduction

To understand associated biological information of amphotericin b, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with amphotericin b

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with amphotericin b?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What lipids are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What genes are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with amphotericin b

Download all related citations
Per page 10 20 50 100 | Total 10373
Authors Title Published Journal PubMed Link
Song Z et al. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. 2019 Carbohydr Polym pmid:30446143
Yamamoto T et al. Claviform aspergillus-related vegetation in the left ventricle of a patient with systemic lupus erythematosus. 2018 J Clin Ultrasound pmid:28568285
Rotjanapan P et al. Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries. 2018 Med. Mycol. pmid:28525619
Foster CE et al. Trichosporonosis in Pediatric Patients With a Hematologic Disorder. 2018 J Pediatric Infect Dis Soc pmid:28510690
Amphornphruet A et al. Endogenous Cryptococcal Endophthalmitis in Immunocompetent Host: Case Report and Review of Multimodal Imaging Findings and Treatment. 2018 Ocul. Immunol. Inflamm. pmid:28448725
Islam S Rapidly progressing facial leishmaniasis: effective treatment with liposomal amphotericin B and a review of the management of Old World cutaneous leishmaniasis. 2018 Paediatr Int Child Health pmid:28281913
Saturnino RS et al. Assessment of the mutagenic, recombinogenic, and carcinogenic potential of amphotericin B in somatic cells of Drosophila melanogaster. 2018 Drug Chem Toxicol pmid:28274136
Uppar A et al. Intracranial Cryptococcoma-Clinicopathologic Correlation and Surgical Outcome: A Single-Institution Experience. 2018 World Neurosurg pmid:29678697
Ravichandran V et al. Synthetic Polysaccharides as Drug Carriers: Synthesis of Polyglucose-Amphotericin B Conjugates and Evaluation of Their Anti-Fungal and Anti-Leishmanial Activities. 2018 J Nanosci Nanotechnol pmid:29442909
Duncan K et al. Efficacy of Amphotericin B Against Fusarium and Aspergillus in Corneal Storage Medium. 2018 Eye Contact Lens pmid:30376531
Vásquez Marcano RGDJ et al. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery. 2018 Carbohydr Polym pmid:30287009
Adamczick C et al. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany - a case report. 2018 BMC Infect. Dis. pmid:30285634
Monroig-Bosque PDC et al. The utility of therapeutic plasma exchange for amphotericin B overdose. 2018 Transfus. Apher. Sci. pmid:30274949
Krishnan RA et al. Protective nature of low molecular weight chitosan in a chitosan-Amphotericin B nanocomplex - A physicochemical study. 2018 Mater Sci Eng C Mater Biol Appl pmid:30274080
Liao H et al. Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report. 2018 Medicine (Baltimore) pmid:30235714
Carbone DCB et al. Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area. 2018 Rev. Inst. Med. Trop. Sao Paulo pmid:30231161
Milan EP et al. Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature. 2018 BMC Infect. Dis. pmid:30227852
Wu T et al. [Clinical high risk factors and prognosis of 25 pulmonary mucormycosis cases]. 2018 Zhonghua Yi Xue Za Zhi pmid:30220143
Fattah SY et al. Tongue necrosis secondary to mucormycosis in a diabetic patient: A first case report in Malaysia. 2018 J Mycol Med pmid:30205883
Navarro-Rodríguez P et al. Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis. 2018 Diagn. Microbiol. Infect. Dis. pmid:30201117
Head K et al. Topical and systemic antifungal therapy for chronic rhinosinusitis. 2018 Cochrane Database Syst Rev pmid:30199594
Wheat J et al. Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. 2018 Medicine (Baltimore) pmid:29595679
Molloy SF et al. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. 2018 N. Engl. J. Med. pmid:29539274
Oyama J et al. American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case. 2018 Rev. Inst. Med. Trop. Sao Paulo pmid:29451600
Eshun-Wilson I et al. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. 2018 Cochrane Database Syst Rev pmid:30039850
Mendonça DVC et al. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. 2018 Exp. Parasitol. pmid:29448040
Zarrinpar A et al. Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. 2018 Nat Commun pmid:30030441
Casa DM et al. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity. 2018 Exp. Parasitol. pmid:30026113
Nayak A et al. A defined medium for Leishmania culture allows definition of essential amino acids. 2018 Exp. Parasitol. pmid:29326050
Ling Q et al. Disseminated histoplasmosis in an immunocompetent patient from an endemic area: A case report. 2018 Medicine (Baltimore) pmid:30024525
Swan CD and Gottlieb T empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature. 2018 BMJ Case Rep pmid:30021735
Khedri S et al. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. 2018 Lett. Appl. Microbiol. pmid:30019443
Xu S et al. Biguanides enhance antifungal activity against Candida glabrata. 2018 Virulence pmid:29962263
Yamazaki H et al. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis. 2018 Diagn. Microbiol. Infect. Dis. pmid:29203252
Coêlho ES et al. Emulgel based on amphotericin B and bacuri butter (Platonia insignis Mart.) for the treatment of cutaneous leishmaniasis: characterization and in vitro assays. 2018 Drug Dev Ind Pharm pmid:29961344
Nieto-Meneses R et al. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. 2018 Exp. Parasitol. pmid:29191699
Werge M et al. Evaluation of local instillation of antibiotics in infected walled-off pancreatic necrosis. 2018 Pancreatology pmid:29958817
Shahani L Disseminated histoplasmosis mimicking relapsed chronic lymphocytic leukaemia. 2018 BMJ Case Rep pmid:29954761
Olías-Molero AI et al. In-Vitro Activity of Silybin and Related Flavonolignans against and . 2018 Molecules pmid:29954145
Yang C et al. Reducing the toxicity of amphotericin B by encapsulation using methoxy poly(ethylene glycol)-b-poly(l-glutamic acid-co-l-phenylalanine). 2018 Biomater Sci pmid:29947373
Jansook P et al. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations. 2018 Drug Dev Ind Pharm pmid:29936874
Fay VDS et al. Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B. 2018 An Bras Dermatol pmid:29924220
Bagshaw E et al. Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK. 2018 Future Microbiol pmid:29911889
Ravichandran V et al. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents. 2018 Curr Drug Deliv pmid:29732967
Shrestha M et al. Visceral leishmaniasis from a non-endemic Himalayan region of Nepal. 2018 Parasitol. Res. pmid:29717371
Nicolas G et al. Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia. 2018 Am J Case Rep pmid:29712885
Franco-Muñoz C et al. Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia. 2018 PLoS ONE pmid:29698432
Zhang J et al. Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation. 2018 BMC Cancer pmid:29695237
Usman F et al. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier. 2018 AAPS PharmSciTech pmid:29691753
Hoarau G et al. [Fungal keratitis: A 5-year monocentric retrospective study on Reunion Island]. 2018 J Fr Ophtalmol pmid:29681463
Bozkurt-Guzel C et al. Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species. 2018 Diagn. Microbiol. Infect. Dis. pmid:29680320
Ponzio V et al. Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system. 2018 Transpl Infect Dis pmid:29677399
Vos FI et al. Eye for an eye: near-fatal outcome of fungal infection in a young, diabetic girl. 2018 BMJ Case Rep pmid:29666080
Bosshardt CR et al. Histoplasma meets Crohn's disease: a rare case of new-onset ascites. 2018 BMJ Case Rep pmid:29666076
Uzun S et al. Clinical practice guidelines for the diagnosis and treatment of cutaneous leishmaniasis in Turkey. 2018 Int. J. Dermatol. pmid:29663351
Mitomo H et al. Endobronchial Topical Amphotericin B Instillation for Pulmonary Chromomycosis After Lung Transplantation: A Case Report. 2018 Transplant. Proc. pmid:29661466
Khan AA et al. Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system. 2018 Eur J Pharm Sci pmid:29653177
Thanki K et al. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B. 2018 Int J Pharm pmid:29635057
Pedroso LS et al. Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B. 2018 Curr Drug Deliv pmid:29629661
Rodriguez-Goncer I et al. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation. 2018 Eur. J. Clin. Microbiol. Infect. Dis. pmid:29623451
Nishioka H et al. Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease. 2018 J. Infect. Chemother. pmid:29021093
Zhang B et al. Improvement of amphotericin B production by a newly isolated Streptomyces nodosus mutant. 2018 Biotechnol. Appl. Biochem. pmid:28762559
Mosimann V et al. Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review. 2018 Acta Trop. pmid:29550282
Posch W et al. Aspergillus terreus: Novel lessons learned on amphotericin B resistance. 2018 Med. Mycol. pmid:29538736
Lei HL et al. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. 2018 Eur. J. Clin. Microbiol. Infect. Dis. pmid:29536323
Jain S et al. Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement. 2018 AAPS PharmSciTech pmid:29532426
Kaneko Y et al. Successful Treatment of Intestinal Mycosis Caused by a Simultaneous Infection with Lichtheimia ramosa and Aspergillus calidoustus. 2018 Intern. Med. pmid:29526942
Efimova SS et al. Lipid-mediated mode of action of local anesthetics on lipid pores induced by polyenes, peptides and lipopeptides. 2018 Colloids Surf B Biointerfaces pmid:29525621
Öner T et al. Rare presentation of Candida albicans: infective endocarditis and a pulmonary coin lesion. 2018 Cardiol Young pmid:29513204
Challener D and Abu Saleh O Disseminated blastomycosis in a transplant patient. 2018 Transpl Infect Dis pmid:29512289
Nambiar P et al. Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation. 2018 Transpl Infect Dis pmid:29512240
Kural C et al. Intracavitary amphotericin B in the treatment of intracranial aspergillosis. 2018 J Clin Neurosci pmid:29506772
Ludwig DB et al. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B. 2018 Mycopathologia pmid:29497926
Kaur L et al. A Mechanistic Study to Determine the Structural Similarities Between Artificial Membrane Strat-Mâ„¢ and Biological Membranes and Its Application to Carry Out Skin Permeation Study of Amphotericin B Nanoformulations. 2018 AAPS PharmSciTech pmid:29488196
Dawgul MA et al. Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates. 2018 Med Chem pmid:29485003
Belmadani A et al. Dermaseptin-S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes. 2018 J. Appl. Microbiol. pmid:29476689
Kimura H et al. Primary cutaneous aspergillosis caused by Aspergillus tamarii in a premature infant with extremely low birthweight: A case report with short review. 2018 J. Dermatol. pmid:29473215
Reichert-Lima F et al. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates. 2018 Mycoses pmid:29468746
Stewart ER et al. Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis. 2018 Mycopathologia pmid:29340909
Sandhya M et al. Amphotericin B loaded sulfonated chitosan nanoparticles for targeting macrophages to treat intracellular Candida glabrata infections. 2018 Int. J. Biol. Macromol. pmid:29339278
Gurudevan S et al. Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity. 2018 Eur J Pharm Sci pmid:29325755
Mohamed HA et al. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study. 2018 Drug Deliv Transl Res pmid:29280061
Polley SD et al. Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK. 2018 Emerging Infect. Dis. pmid:29260661
Yoshida M et al. Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications. 2018 Mycopathologia pmid:29249044
Chao J et al. Follicular papules and pustules in a patient with pulmonary symptoms. 2018 Clin. Exp. Dermatol. pmid:29226980
Lima MR et al. Hydrophobization of cashew gum by acetylation mechanism and amphotericin B encapsulation. 2018 Int. J. Biol. Macromol. pmid:29225182
Aparna V et al. Carboxymethylated É©-carrageenan conjugated amphotericin B loaded gelatin nanoparticles for treating intracellular Candida glabrata infections. 2018 Int. J. Biol. Macromol. pmid:29169943
Vanam HP et al. Distal Lateral Subungual Onychomycosis Owing to Tritirachium oryzae: A Bystander or Invader? 2018 Mycopathologia pmid:29164433
Rodrigo C et al. Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies. 2018 Clin. Microbiol. Infect. pmid:29138100
Venturini TP et al. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism. 2018 Int. J. Antimicrob. Agents pmid:29127050
Ravichandran V and Jayakrishnan A Synthesis and evaluation of anti-fungal activities of sodium alginate-amphotericin B conjugates. 2018 Int. J. Biol. Macromol. pmid:29126939
Vaezi A et al. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex. 2018 Mycoses pmid:29064123
Che YM et al. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis. 2018 J. Cell. Biochem. pmid:29058791
Watanabe A et al. Stability and drug release studies of an antimycotic nanomedicine using HPLC, dynamic light scattering and atomic force microscopy. 2018 J Pharm Biomed Anal pmid:29028561
He R et al. Report of 12 cases with tracheobronchial mucormycosis and a review. 2018 Clin Respir J pmid:29028140
Cavalcante CSP et al. Insights into the candidacidal mechanism of Ctn[15-34] - a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins. 2018 J. Med. Microbiol. pmid:29214974
Kassi FK et al. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast. 2018 J. Med. Microbiol. pmid:29214970
Leonhard V et al. Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects. 2018 Curr Drug Deliv pmid:28925873
Falces-Romero I et al. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital. 2018 Mycoses pmid:28922488
Rizzello I et al. Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia. 2018 Mycoses pmid:28872724